176 related articles for article (PubMed ID: 38711500)
1. Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still's disease and their association with cytokines.
Yoshida S; Koga T; Fujita Y; Yatsuhashi H; Matsumoto H; Sumichika Y; Saito K; Sato S; Asano T; Kobayakawa M; Ohira H; Mizokami M; Sugiyama M; Migita K
Front Immunol; 2024; 15():1385654. PubMed ID: 38711500
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease.
Chen PK; Lan JL; Li JP; Chang CK; Chang SH; Huang PH; Yeo KJ; Chen DY
Clin Rheumatol; 2020 Jun; 39(6):1945-1952. PubMed ID: 31960208
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
4. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
[TBL] [Abstract][Full Text] [Related]
6. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.
Chen PK; Lan JL; Huang PH; Hsu JL; Chang CK; Tien N; Lin HJ; Chen DY
Front Immunol; 2021; 12():719544. PubMed ID: 34367188
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.
Zhu D; Chen L; Meng J; Wang M; Ma Y; Chen X; Xiao Y; Yi D; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Zhou Z; Yang C; Teng J; Jia J; Hu Q
J Autoimmun; 2024 Apr; 144():103182. PubMed ID: 38460457
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
[TBL] [Abstract][Full Text] [Related]
10. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still's disease.
Fujita Y; Yago T; Asano T; Matsumoto H; Matsuoka N; Temmoku J; Sato S; Yashiro-Furuya M; Suzuki E; Watanabe H; Kawakami A; Migita K
PLoS One; 2021; 16(8):e0255493. PubMed ID: 34351954
[TBL] [Abstract][Full Text] [Related]
12. Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome.
Kasama T; Furuya H; Yanai R; Ohtsuka K; Takahashi R; Yajima N; Miwa Y; Kobayashi K
Clin Rheumatol; 2012 May; 31(5):853-60. PubMed ID: 22322207
[TBL] [Abstract][Full Text] [Related]
13. Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still's disease: A prospective cohort study.
Zhang W; Yang T; Zhang H; Xu Y; Yang Q; Liu Q; Gao Y; Wu J; Shao L; Zhang W
Cytokine; 2021 Oct; 146():155642. PubMed ID: 34325118
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
[TBL] [Abstract][Full Text] [Related]
15. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
[TBL] [Abstract][Full Text] [Related]
16. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease.
Han JH; Suh CH; Jung JY; Ahn MH; Kwon JE; Yim H; Kim HA
J Rheumatol; 2017 Jun; 44(6):740-747. PubMed ID: 28365573
[TBL] [Abstract][Full Text] [Related]
17. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
Kim HA; An JM; Nam JY; Jeon JY; Suh CH
J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of free interleukin-18 in adult-onset Still's disease.
Girard C; Rech J; Brown M; Allali D; Roux-Lombard P; Spertini F; Schiffrin EJ; Schett G; Manger B; Bas S; Del Val G; Gabay C
Rheumatology (Oxford); 2016 Dec; 55(12):2237-2247. PubMed ID: 27616144
[TBL] [Abstract][Full Text] [Related]
19. Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease.
Hu Q; Shi H; Zeng T; Liu H; Su Y; Cheng X; Ye J; Yin Y; Liu M; Zheng H; Wu X; Chi H; Zhou Z; Jia J; Sun Y; Teng J; Yang C
Arthritis Res Ther; 2019 Jan; 21(1):9. PubMed ID: 30616678
[TBL] [Abstract][Full Text] [Related]
20. Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.
Shimojima Y; Ichikawa T; Kishida D; Takamatsu R; Sekijima Y
Clin Exp Immunol; 2021 Nov; 206(2):184-195. PubMed ID: 34319596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
